Cargando…
Breast cancer prevention by short-term inhibition of TGFβ signaling
Cancer prevention has a profound impact on cancer-associated mortality and morbidity. We previously identified TGFβ signaling as a candidate regulator of mammary epithelial cells associated with breast cancer risk. Here, we show that short-term TGFBR inhibitor (TGFBRi) treatment of peripubertal ACI...
Autores principales: | Alečković, Maša, Cristea, Simona, Gil Del Alcazar, Carlos R., Yan, Pengze, Ding, Lina, Krop, Ethan D., Harper, Nicholas W., Rojas Jimenez, Ernesto, Lu, Donghao, Gulvady, Anushree C., Foidart, Pierre, Seehawer, Marco, Diciaccio, Benedetto, Murphy, Katherine C., Pyrdol, Jason, Anand, Jayati, Garza, Kodie, Wucherpfennig, Kai W., Tamimi, Rulla M., Michor, Franziska, Polyak, Kornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729304/ https://www.ncbi.nlm.nih.gov/pubmed/36476730 http://dx.doi.org/10.1038/s41467-022-35043-5 |
Ejemplares similares
-
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
por: Alečković, Maša, et al.
Publicado: (2023) -
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
por: Janiszewska, Michalina, et al.
Publicado: (2019) -
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2(+) breast cancer
por: Janiszewska, Michalina, et al.
Publicado: (2021) -
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
por: Gil Del Alcazar, Carlos R., et al.
Publicado: (2022) -
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
por: Ge, Jennifer Y., et al.
Publicado: (2020)